Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Yoshiya Tanak"'
Autor:
Iain B. McInnes, Philip J. Mease, Yoshiya Tanaka, Laure Gossec, M. Elaine Husni, Lars Erik Kristensen, Richard B. Warren, Barbara Ink, Rajan Bajracharya, Jason Coarse, Alice B. Gottlieb
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 11, Pp 720-731 (2024)
Objective The objective of this study was to assess 52‐week efficacy and safety of bimekizumab in patients with active psoriatic arthritis (PsA) with or without concomitant methotrexate (+/−MTX) treatment at baseline. Methods We conducted a post
Externí odkaz:
https://doaj.org/article/9bc82b35361540eca261704dc88423d0
Autor:
Philip J. Mease, Joseph F. Merola, Yoshiya Tanaka, Laure Gossec, Iain B. McInnes, Christopher T. Ritchlin, Robert B. M. Landewé, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1363-1382 (2024)
Abstract Introduction Psoriatic arthritis (PsA) is a chronic inflammatory disease requiring long-term treatment. Bimekizumab, a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A, has demonstrated tolerabili
Externí odkaz:
https://doaj.org/article/4bbb5fc59b154e17b4cb6d05b6603d8e
Autor:
Naoaki Ohkubo, Yusuke Miyazaki, Shingo Nakayamada, Shunsuke Fukuyo, Yoshino Inoue, Yurie Satoh-Kanda, Hiroaki Tanaka, Yasuyuki Todoroki, Hiroko Miyata, Atsushi Nagayasu, Masashi Funada, Hiroki Kobayashi, Hidenori Sakai, Shumpei Kosaka, Satsuki Matsunaga, Yukiko Tomoyose, Hirotsugu Nohara, Yoshiya Tanaka
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1303-1319 (2024)
Abstract Introduction The study aimed to determine the efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in the treatment of polymyalgia rheumatica (PMR) complicated by rheumatoid arthritis (RA). Methods Patients with
Externí odkaz:
https://doaj.org/article/4bf563ac6abb415f8bae6b44e3ae265f
Autor:
Hendrik Schulze-Koops, Tsutomu Takeuchi, Daniel Aletaha, Maya H Buch, Yoshiya Tanaka, Ricardo Blanco, Paul Emery, Jacques-Eric Gottenberg, Bernard G Combe, Roberto Caporali, Patrick Verschueren, Vijay Rajendran, Anna Zubrzycka-Sienkiewicz, Edmund V Ekoka Omoruyi, Francesco De Leonardis
Publikováno v:
RMD Open, Vol 10, Iss 4 (2024)
Background Janus kinase inhibitors are an effective option for achieving sustained remission or low disease activity in patients with rheumatoid arthritis (RA) following inadequate response to conventional synthetic disease-modifying anti-rheumatic d
Externí odkaz:
https://doaj.org/article/876c49e5e08a4163a919ba3850e5bc79
Autor:
Yoshiya Tanaka, Mitsumasa Kishimoto, Koshiro Sonomoto, Koichi Amano, Masayoshi Harigai, Alina Onofrei, Jacqueline O’Brien, Zachary Margolin, Christine Barr, Yasushi Mizuno, Ekta Agarwal, Naonobu Sugiyama, Hisashi Yamanaka
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1237-1253 (2024)
Abstract Introduction The evolution of disease-modifying antirheumatic drugs (DMARDs) for the treatment of rheumatoid arthritis (RA) has improved patient prognosis. However, more real-world safety/effectiveness data comparing methotrexate (MTX), tofa
Externí odkaz:
https://doaj.org/article/bd4e692904d347f48204599691f8f2c3
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Background Rheumatoid arthritis (RA) patients sometimes exhibit different levels of improvement in health assessment questionnaire-disability index (HAQ-DI) and subjective pain visual analogue score (VAS) even after achieving low disease act
Externí odkaz:
https://doaj.org/article/dc418882d11e475aaf157757a44101d5
Publikováno v:
Inflammation and Regeneration, Vol 44, Iss 1, Pp 1-11 (2024)
Abstract Background Interstitial lung diseases (ILDs) are a diverse group of conditions characterized by inflammation and fibrosis in the lung. In some patients with ILD, a progressive fibrotic phenotype develops, which is associated with an irrevers
Externí odkaz:
https://doaj.org/article/f9945956d3ef49b7ab8205a8dda413ce
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Impaired insulin secretory capacity is associated with high glycemic variability in patients with type 2 diabetes (T2DM). However, there are no existing reports on the association between insulin secretory capacity and time in range (TIR). T
Externí odkaz:
https://doaj.org/article/c9cfa9902f1b4a749ec4d871fb784c4d
Autor:
Tsutomu Takeuchi, Yoshiya Tanaka, Rangi Kandane-Rathnayake, Ning Li, Sang-Cheol Bae, Zhanguo Li, Shereen Oon, Vera Golder, Mandana Nikpour, Masayoshi Harigai, Yi-Hsing Chen, Zhuoli Zhang, Eric Morand, Chak Sing Lau, Worawit Louthrenoo, Alberta Hoi, Sandra Navarra, Sean O’Neill, Shue-Fen Luo, Jun Kikuchi, Yanjie Hao, Yasuhiro Katsumata, Aisha Lateef, Laniyati Hamijoyo, Sargunan Sockalingam, Nicola Tugnet, Madelynn Chan, Jiacai Cho, Leonid Zamora, Fiona Goldblatt, Kristine Ng, Yeong-Jian Jan Wu, Dylan Hansen, B M D B Basnayake
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 2 (2024)
Objectives The lupus low disease activity state (LLDAS) allows for certain clinical and/or serological activity of SLE, provided overall disease activity does not exceed predefined cut-offs. This study aimed to evaluate the outcomes of patients who a
Externí odkaz:
https://doaj.org/article/cb33790523424640ae42812b39be75b7
Autor:
Tomonori Ishii, Yoshiya Tanaka, Atsushi Kumanogoh, Tatsuya Atsumi, Shizuo Akira, Fumitoshi Tago, Mari Aoki, Shintaro Yamamuro
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objectives To evaluate the safety, tolerability, pharmacokinetics (PK), biomarker response and efficacy of E6742 in a phase I/II study in patients with systemic lupus erythematosus (SLE).Methods Two sequential cohorts of patients with SLE were enroll
Externí odkaz:
https://doaj.org/article/753df8e68c964679a4aa43721d3f2929